Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.

Recent Blog Posts

Dear Research Advocate, This week’s headlines about the coronavirus certainly underscore how nimble and prepared our federal research agencies must always be. It’s a compelling reason health research agencies must be well-funded and well-coordinated. The CDC, FDA, and NIH trifecta are on high alert, playing leading roles in global efforts to identify and contain the deadly virus. After Chinese researchers sequenced the virus’ genome, they posted it in GenBank, a database managed by NIH. The CDC has submitted a diagnostic test to the FDA for use in select public health labs around the country. NIH is working with industry on a vaccine they hope to have ready for human trials in a few months...
As Research!America prepares for our 24 th Advocacy Awards Dinner , we want readers to learn more about our award recipients. Every Tuesday leading up to the March 11, 2020 event, we will post a short interview with our esteemed honorees. Myron M. Levine, MD, DTPH Associate Dean for Global Health, Vaccinology & Infectious Diseases, Center for Vaccine Development and Global Health, University of Maryland School of Medicine When did you know you were an advocate for scientific research and innovation? In progressive steps, during medical school, pediatric residency, infectious diseases fellowship, as an Epidemic Intelligence Service Officer of the Centers for Disease Control and...
Dear Research Advocate, Last summer, the administration announced a new policy targeting fetal tissue research. The Washington Post reported this week on the troubling consequences for scientists, scientific progress, and thus patients. Research!America stood with patients and researchers against this retrograde policy change when it was first contemplated and, as part of a coalition led by the International Society for Stem Cell Research (ISCCR), we continue to push back. (It’s well to remember that fetal tissue research is not only playing a significant role today in research for vaccine development, Down syndrome, MS, and Parkinson’s, but its untapped potential holds significance for...
Dear Research Advocate: As 2020 begins, you no doubt have made personal and professional resolutions. How could you not? With information concerning exercise , diet , and smoking cessation flooding our screens, one feels almost left out if not pledging improvement. (The links above are to evidence-based sources only; not current reality, but hope springs eternal). Here are a few advocacy resolutions to consider: Resolution1: Celebrate your successes! Members of the Research!America Alliance have much to be proud of and grateful for as we look back at 2019. Individually and collectively, day in and day out, we spoke out: we made the case for raising the budget caps, boosting science funding...
Dear Research Advocate, Happy New Year! As our blue marble makes another trip around the sun, a new year and a new decade call out for inspiration. Recent Nobelist and Johns Hopkins University professor Dr. Gregg Semenza has written about what he wishes everyone knew about science . The imperatives of basic research, collaboration, perseverance, mentorship — along with the contributions of young scientists — are valued dimensions of science we all can and should communicate widely in the new year. Speaking of young scientists, kudos to pharmacy doctoral student Camille Schrier, who was crowned Miss America 2020 last month. A graduate of Virginia Tech , Ms. Schrier brought her love of...
As 2019 comes to a close, we’re taking a look back at our 10 most popular blog posts (based on page views) for the year. The posts cover a wide range of topics including basic and clinical research, public health, global health and the successful Raise the Caps campaign. We thank our distinguished group of guest bloggers including young researchers, academics, industry experts, public health professionals, and patient advocates as well as staff here at Research!America who are united in their support for stronger investments in research and innovation to combat diseases and build a safer, healthier nation. 1) Research America Launches Raise the Caps Campaign March 19 : In our most-read post...
Dear Research Advocate, Almost three months into the 2020 fiscal year, Congress has finally passed a legislative package to fund the federal government. As of press time, the Senate is expected to finish clearing the package tonight. The White House has indicated that the President will sign, thus avoiding a shutdown at midnight on Friday. There are many positive developments for the medical and science research advocacy community in these bills, including: A significant funding increase of $2.6 billion for NIH, paving the way for faster medical progress and more lifesaving, job-producing R&D. An increase of $636 million for the CDC, including new resources to strengthen the agency’s 24...
Dear Research Advocate, Earlier today, the good news broke that Congress and the White House have reached a tentative agreement (emphasis on “tentative”) on Fiscal Year 2020 funding. We are hearing that if all goes as planned (emphasis on “if” and “planned”), the House and Senate will vote on two appropriations minibuses next week and the president will sign them into law before the current stop-gap funding measure expires on December 20, 2019. The first minibus would reportedly include the “Labor-H” bill, which funds NIH, CDC, and AHRQ, as well as the Agriculture and “CJS” bills, the first of which includes funding for FDA and the second, NSF. The other minibus would include the Homeland...
Dear Research Advocate, The 2016 21st Century Cures Act (21stCC) is a prime example of patient groups, government, the private sector, academia and other research stakeholders working together toward a common goal: accelerating medical progress. With new thinking and new funding, 21stCC has empowered our nation to work more quickly to address rare diseases and chart new territory in areas such as regenerative medicine and brain science. (And that’s just scratching the surface.) We can’t overstate the credit due the policymakers spearheading 21stCC for their leadership, commitment and determination. Now the same team — Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) — is working...
Dear Research Advocate, Happy Thanksgiving Week! Every Monday before Thanksgiving Research!America hosts Public Health Thank You Day (PHYTD), thanking the individuals across the nation who serve the public health. With participation by so many of you, we garnered 27 million impressions on Twitter with nearly 500 unique tweets by public health organizations and leaders. Federal officials taking part included Secretary of HHS Alex Azar; Surgeon General Dr. Jerome Adams; CDC Director Robert Redfield; NIH Director Francis Collins; NIAID Director Anthony Fauci; Assistant Secretary of Health and Acting FDA Commissioner Brett Giroir; VHA Deputy Undersecretary for Health Carolyn Clancy and many...

Pages

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco